This year has so far consisted of a number of significant additions to the NuVision team. This month, we are delighted to announce the appointment of our new Sales and Marketing Director, Jonathan Hamill-Keays, who will lead and work alongside our new Territory...
NuVision Biotherapies is delighted to announce that Roger Teasdale has joined the Board as an Independent Non-Executive Director. Roger enjoyed a successful 25 year career at Smith & Nephew, the FTSE 100 Medical device business focused on the Advanced Wound...
NuVision Biotherapies is delighted to announce the appointment of its new chairman, Dr Mark Treherne. Mark has a PhD in Pharmacology from Cambridge University along with over 25 years of industrial R&D experience in the discovery and development of novel...
